MedPath

Health Benefits of Whole-body Vibration

Not Applicable
Recruiting
Conditions
Whole-body Vibration
Interventions
Other: Sub Acute Whole Body Vibration Training
Registration Number
NCT05097885
Lead Sponsor
Augusta University
Brief Summary

The overall goals of this pilot investigation are to determine 1) the feasibility of conducting home based WBV studies, and 2) to determine if sub-acute home based WBV can improve a) exercise capacity, b) conduit- and micro- vascular function, and c) skeletal muscle function.

Detailed Description

Cardiovascular disease (CVD) is the leading cause of death in the world and many comorbid conditions (i.e. diabetes, obesity) can affect overall CVD risk. There is increasing interest into the role that skeletal muscle health plays in mediating CVD risk, particularly in metabolic disease states (ie. obesity and diabetes). Whole body vibration (WBV) has emerged as an exercise mimetic that may be more tolerable than traditional modes of exercise, such as treadmill walking/running or cycling. Similar to traditional exercise modalities, WBV can elicit beneficial metabolic effects. In fact, a single bout of WBV increases circulating concentrations of IL-6, which correspond with the normalization of glucose and insulin in obese individuals. The proposed pilot investigation will provide the foundation to begin understanding the molecular and physiological mechanisms of how sub-acute WBV can improve overall CVD risk. We hypothesize that home based WBV will decrease CVD risk by improving skeletal muscle and vascular function via a decrease in systemic inflammation.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Men and women (> 18 yrs old)
  • All races
Read More
Exclusion Criteria
  • <18 years old
  • Clinical diagnosis of hepatic, cardiovascular, or renal disease
  • Diabetic complications (i.e. macrovascular, microvascular, or autonomic)
  • Pregnancy
  • Direct vasoactive medications (i.e. nitrates)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Sub Acute (12 week) Whole Body TrainingSub Acute Whole Body Vibration Training-
Primary Outcome Measures
NameTimeMethod
Change in VO2 Peakpre-treatment baseline and following 12 weeks sub-acute whole-body vibration

change from baseline relative (mL/kg/min) peak oxygen consumption (VO2) during maximal exercise test at 12 weeks

Change in Flow-Mediated Dilation (FMD)pre-treatment baseline and following 12 weeks sub-acute whole-body vibration

change from baseline brachial artery flow mediated dilation at 12 weeks.

Change in Skeletal Muscle Mitochondrial Functionpre-treatment baseline and following 12 weeks sub-acute whole-body vibration

change from baseline skeletal muscle mitochondrial function at 12 weeks. Measured using Near Infrared Spectroscopy (NIRS). Values are an index of phosphocreatine recovery expressed as a rate constant (min-1)

Change in Pulse Wave Velocity (PWV)pre-treatment baseline and following 12 weeks sub-acute whole-body vibration

Change from baseline PWV at 12 weeks. Measured by Shygmocor Xcel in m/s.

Change in Post Occlusive Reactive Hyperemia (PORH)pre-treatment baseline and following 12 weeks sub-acute whole-body vibration

Change from baseline PORH at 12 weeks. Measured by Laser Speckle Contrast Imager (Moor FLPI).

Change in IL-6pre-treatment baseline and following 12 weeks sub-acute whole-body vibration

change from baseline concentrations of Interleukin 6 (IL-6) obtained via blood draw at 12 weeks.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Augusta University/Georgia Prevention Institute/ Laboratory of Integrative and Exercise Physiology

🇺🇸

Augusta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath